UPDATE 3-Abbvie to partner with Denmark's Genmab in $750 mln cancer therapy deal

Abbvie Inc said on Wednesday it is partnering with Danish biotech firm Genmab AS to jointly develop and market cancer treatments, as it looks to expand its cancer franchise.